Search

Elhusseiny, Abdelrahman, Ryan Gise, and Iason Mantagos. 2021. “Trochleitis Presenting With Double Vision in a Patient With Juvenile Idiopathic Arthritis”. Orbit 40 (4): 342-43.

Bakshi, Shaunak, Allen Ho, James Chodosh, Adrian Fung, Paul Chan, and Daniel Shu Wei Ting. 2020. “Training in the Year of the Eye: The Impact of the COVID-19 Pandemic on Ophthalmic Education”. Br J Ophthalmol 104 (9): 1181-83.

Elhusseiny, Abdelrahman, and Deborah VanderVeen. 2020. “Outcomes of Glaucoma Drainage Devices in Childhood Glaucoma”. Semin Ophthalmol, 1-11.

Yang, Yanhui, Xionggao Huang, Gaoen Ma, Jing Cui, Joanne Aiko Matsubara, Andrius Kazlauskas, Jun Zhao, Jiantao Wang, and Hetian Lei. 2020. “PDGFRβ Plays an Essential Role in Patient Vitreous-Stimulated Contraction of Retinal Pigment Epithelial Cells from Epiretinal Membranes”. Exp Eye Res 197: 108116.

Moustafa, Giannis, Allan Topham, Mary Aronow, and Demetrios Vavvas. 2020. “Paediatric Ocular Adnexal Lymphoma: A Population-Based Analysis”. BMJ Open Ophthalmol 5 (1): e000483.

Agrawal R MD, FCRS, Gunasekeran DV MBBS, Agarwal MS, Testi MD, Carreño MD, Westcott FRCOphth, Mahajan MBBS, et al. 2020. “Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6”. Ocul Immunol Inflamm, 1-9.

FCRS, Agrawal MD, Betzler MBBS, Testi MD, Mahajan MBBS, Agarwal MS, Gunasekeran DV MD, Raje PhD, et al. 2020. “The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients With Tubercular Anterior Uveitis”. Ocul Immunol Inflamm, 1-10.

Ung, Cindy, Tomasz Stryjewski, and Dean Eliott. 2020. “Indications, Findings, and Outcomes of Pars Plana Vitrectomy After Open Globe Injury”. Ophthalmol Retina 4 (2): 216-23.

Charles, Norman, Frederick Jakobiec, Jillian Chong, Kyle Godfrey, Payal Patel, and Lina Ma. 2020. “Congenital Respiratory-Type Ciliated Cyst of the Lacrimal Sac”. Can J Ophthalmol 55 (1): e30-e33.

Guan, Ji-Tian, Xin-Xin Li, De-Wei Peng, Wen-Meng Zhang, Jia Qu, Fan Lu, Robert D’Amato, and Zai-Long Chi. 2020. “MicroRNA-18a-5p Administration Suppresses Retinal Neovascularization by Targeting FGF1 and HIF1A”. Front Pharmacol 11: 276.